Business Context and Reporting Period
Company: AMN Healthcare Services, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 9, 2018
Event: Entry into a new Material Definitive Agreement (Credit Agreement) and termination of the prior credit facility.
Key Financial Metrics and Facility Details
This filing details the restructuring of the company's debt facilities rather than reporting operational financial results (revenue, profit, or cash flow) for a specific period.
- New Credit Facility: $400 million secured revolving credit facility (Revolver).
- Sublimits: $50 million for standby letters of credit and $50 million for swingline loans.
- Incremental Capacity: Potential to increase by up to $250 million plus additional amounts subject to a Consolidated Secured Net Leverage Ratio not exceeding 2.25 to 1.00.
- Maturity Date: February 9, 2023.
- Interest Rates: Floating rates based on LIBOR (plus 1.00% to 2.00%) or Base Rate (plus 0.00% to 1.00%), dependent on leverage ratios.
- Fees: Unused fee of 0.20% to 0.35% per annum; Letter of credit fees of 1.00% to 2.00% per annum.
- Outstanding Borrowings: $0 under the terminated prior facility at the time of the new agreement.
- Letters of Credit Rolled Over: Approximately $19,320,000 from the prior facility.
Material Changes Versus Prior Period
The primary material change is the replacement of the Prior Credit Agreement (dated April 18, 2014) with a new Credit Agreement effective February 9, 2018.
- Termination: The Prior Credit Agreement was terminated immediately upon the execution of the new agreement.
- Structure: The new facility maintains a revolving structure but introduces specific sublimits for letters of credit and swingline loans, and establishes a framework for incremental term loans.
- Covenants: The new agreement imposes specific financial covenants not explicitly detailed in the summary of the prior agreement within this text.
Guidance, Outlook, Risks, and Covenants
Financial Covenants:
- Maximum Consolidated Net Leverage Ratio: 3.75 to 1.00.
- Minimum Consolidated Interest Coverage Ratio: 2.50 to 1.00.
Restrictions: The agreement includes customary affirmative and negative covenants, including limitations on the ability to declare and pay dividends.
Risks: Payment obligations may be accelerated upon the occurrence of defined events of default. The company is subject to variable interest rates tied to market benchmarks (LIBOR/Prime).
Management Commentary: The filing does not contain forward-looking guidance on revenue or earnings. The facility is designated for working capital, capital expenditures, permitted acquisitions, and general corporate purposes.
Important Facts for Investor Verification
- Verify the company's current Consolidated Net Leverage Ratio and Interest Coverage Ratio to ensure compliance with the new 3.75x and 2.50x covenants.
- Confirm the status of the $19.32 million in standby letters of credit rolled over from the previous facility.
- Monitor the company's ability to secure additional commitments for the potential $250 million incremental increase, which requires lender approval.
- Review the full text of the Credit Agreement (Exhibit 10.1, referenced but not included in this summary) for specific definitions of "Consolidated Net Leverage Ratio" and "Consolidated Interest Coverage Ratio."
- Assess the impact of the dividend restrictions on shareholder returns.